rs769198
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_000845.3(GRM8):c.1464C>T(p.Ile488Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00222 in 1,613,276 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0026 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 12 hom. )
Consequence
GRM8
NM_000845.3 synonymous
NM_000845.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.408
Publications
5 publications found
Genes affected
GRM8 (HGNC:4600): (glutamate metabotropic receptor 8) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.4).
BP6
Variant 7-126609392-G-A is Benign according to our data. Variant chr7-126609392-G-A is described in ClinVar as Benign. ClinVar VariationId is 782707.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.408 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 12 gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRM8 | NM_000845.3 | c.1464C>T | p.Ile488Ile | synonymous_variant | Exon 8 of 11 | ENST00000339582.7 | NP_000836.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GRM8 | ENST00000339582.7 | c.1464C>T | p.Ile488Ile | synonymous_variant | Exon 8 of 11 | 5 | NM_000845.3 | ENSP00000344173.2 |
Frequencies
GnomAD3 genomes AF: 0.00258 AC: 393AN: 152174Hom.: 1 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
393
AN:
152174
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00356 AC: 894AN: 251368 AF XY: 0.00327 show subpopulations
GnomAD2 exomes
AF:
AC:
894
AN:
251368
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00218 AC: 3191AN: 1460984Hom.: 12 Cov.: 29 AF XY: 0.00209 AC XY: 1521AN XY: 726828 show subpopulations
GnomAD4 exome
AF:
AC:
3191
AN:
1460984
Hom.:
Cov.:
29
AF XY:
AC XY:
1521
AN XY:
726828
show subpopulations
African (AFR)
AF:
AC:
23
AN:
33470
American (AMR)
AF:
AC:
397
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
AC:
4
AN:
26128
East Asian (EAS)
AF:
AC:
53
AN:
39672
South Asian (SAS)
AF:
AC:
24
AN:
86218
European-Finnish (FIN)
AF:
AC:
537
AN:
53412
Middle Eastern (MID)
AF:
AC:
7
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
1993
AN:
1111260
Other (OTH)
AF:
AC:
153
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
142
284
425
567
709
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00258 AC: 393AN: 152292Hom.: 1 Cov.: 33 AF XY: 0.00306 AC XY: 228AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
393
AN:
152292
Hom.:
Cov.:
33
AF XY:
AC XY:
228
AN XY:
74472
show subpopulations
African (AFR)
AF:
AC:
21
AN:
41572
American (AMR)
AF:
AC:
62
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
8
AN:
5188
South Asian (SAS)
AF:
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
AC:
113
AN:
10600
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
156
AN:
68022
Other (OTH)
AF:
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
17
35
52
70
87
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
22
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.